Contact
Please use this form to send email to PR contact of this press release:
Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care
TO: